Clinical Trial

Outcomes of Empiric Antibiotic Therapy Based on Hospital Antibiograms in Organ Transplant Recipients with Bacteraemia

Enrolling by Invitation
View on ClinicalTrials.gov →
Record status
This record was last updated March 13, 2025 (before its estimated January 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
The purpose of this observational study is to examine how using the hospital cumulative antibiogram to guide empirical antibiotic therapy affects outcomes in patients with bloodstream infections who have undergone solid organ transplants. The key question is: does the use of a hospital cumulative antibiogram reduce mortality and improve outcomes in these patients?
Trial Details
NCT Number NCT06874920
Lead Sponsor Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Conditions Bacteremia, Transplant Recipient
Enrollment 150 participants
Start Date 2024-12-03
Primary Completion 2026-01-01 (estimated)
Study Completion 2027-01-01 (estimated)
Updated on ClinicalTrials.gov 2025-03-13